The present invention is directed to methods for treating metabolic disorders with compounds that are conjugates. The conjugates of the present invention are comprised of salicylic acid, triflusal, diflusinal, salsalate, IMD-0354, ibuprofen, diclofenac, licofelone, or HTB, and one or more antioxidants.

 
Web www.patentalert.com

< METHODS AND COMPOSITIONS FOR USE IN HOMOLOGOUS RECOMBINATION

> Use of creatine analogues and creatine kinase modulators for the prevention and treatment of obesity and its related disorders

> AGENT FOR PREVENTING ARTERIOSCLEROSIS, AGENT FOR SUPPRESSING VASCULAR INTIMAL THICKENING AND AGENT FOR IMPROVING VASCULAR ENDOTHELIAL FUNCTION
~ 00564